Archives

by in
Entry Author Date Location
Microbiome Startup Seres Health Tabs Pharma Vet Pomerantz as CEO 06/02/14 Boston
AvidBiotics Taps Nature for Two Ways To Fight Lethal Microbes 04/03/14 San Francisco
Flagship Takes a Stab at Microbiome Therapy With Seres Health 11/21/13 Boston
Cubist Adds Antibiotic Punch, Buys Trius and Optimer for $1.24B 07/30/13 Boston
Synthetic Biologics, Fuelled by Billionaire, Takes Aim at C.Diff 05/02/13 Detroit
San Diego Life Sciences Roundup: Optimer, Volcano, Avelas Bio, & More 12/07/12 San Diego
AvidBiotics Sees New Angle for Personalized Medicine in Antibiotics 02/01/12 San Francisco
Optimer, Following Pfizer’s Playbook, Has Big Plans for Antibiotic 01/31/12 San Diego
San Diego Life Sciences Roundup: BeneChill, Sotera, Imthera, & More 12/16/11 San Diego
Optimer Wins EU Approval for New Antibiotic 12/12/11 San Diego
Rempex Raises $67.5M, Vertex Shares Tumble, & More San Diego Life Sciences News 11/10/11 San Diego
FDA Approves Optimer Antibiotic, Amylin Wins Legal Round Against Lilly, Investors Excited by Orexigen Move, & More San Diego Life Sciences News 06/02/11 San Diego
Optimer Cruises Into Memorable Memorial Day Weekend, Awaiting FDA Word on Antibiotic 05/27/11 San Diego
Optimer Antibiotic Gets Panel Nod, CareFusion Buys Vestara, Tracon Raises $16.5M, & More San Diego Life Sciences News 04/07/11 San Diego
Optimer Wins FDA Panel Nod, Still Wrestling With Language to Describe Benefit 04/05/11 San Diego
Biotechies Need to Get Serious About Antibiotics, Where There is Money to Be Made 04/04/11 National
Illumina Rides Business Surge, IntegenX Acquires GenValult, Orexigen Cuts Payroll, & More San Diego Life Science News 02/10/11 San Diego
Optimer Pockets $68M Upfront From Astellas For Rights to Antibiotic in Europe 02/07/11 San Diego
Optimer Seeks Fast Review of Drug for Intestinal Infection, Histogen Raises $10M, TSRI Shares its “Click” Chemistry in Deal with Massachusetts Biotech, & More San Diego Life Sciences News 12/02/10 San Diego
Optimer Seeks Quick Green Light From FDA for Antibiotic Against Deadly Bug 11/30/10 San Diego
Optimer Halts Study After Antibiotic for Traveler’s Diarrhea Linked to Rash; Shares Drop 11/10/10 San Diego
Conatus Gets Idun, Trius Goes Public, BrainCells Gets Sabcomeline, & More San Diego-Area Life Sciences News 08/05/10 San Diego
Optimer Hires New CEO 05/06/10 San Diego
Optimer Nets $51.5M 03/01/10 San Diego
Optimer Rises on Takeover Buzz and Clinical Trial Results; Still Faces Business Risks 02/08/10 San Diego
Optimer Passes Second Big Trial of Drug for Deadly Bacteria 02/04/10 San Diego
UK’s Enigma Diagnostics to Establish U.S. Headquarters in San Diego 10/27/09 San Diego
Optimer Rides Investment See-Saw With Promising Drug for “C.diff” Infections 06/05/09 San Diego
Optimer To Seek EU Approval 03/02/09 San Diego
Optimer Shares Skyrocket, as Drug Halts Deadly Bacterial Infection in Trial 11/10/08 San Diego
Page 1 of 2 next page »